Related Experiment Video
Updated: Jun 7, 2026
12:08
Improving IV Insulin Administration in a Community Hospital
Published on: June 11, 2012
Self-management problem solving for adolescents with type 1 diabetes: intervention processes associated with an
Shelagh A Mulvaney1, Russell L Rothman, Chandra Y Osborn
1School of Nursing, Vanderbilt University Medical Center, Nashville, TN 37240, USA. shelagh.mulvaney@vanderbilt.edu
Patient Education and Counseling
|October 30, 2010
Summary
This study shows adolescents with type 1 diabetes can overcome psychosocial self-management barriers using an internet-based problem-solving program. The program effectively addressed diabetes-related issues, offering a viable solution for improving pediatric diabetes care.
Area of Science:
- Digital Health Interventions
- Adolescent Health
- Diabetes Management
Background:
- Adolescents with type 1 diabetes face psychosocial barriers to self-management.
- Effective interventions are needed to support self-care in this population.
Purpose of the Study:
- To describe intervention processes of an internet self-management problem-solving program for adolescents with type 1 diabetes.
- To examine relationships between participant characteristics and program use.
Main Methods:
- Forty-one adolescents (aged 13-17) with type 1 diabetes participated in an internet-based intervention.
- The program involved guided problem-solving cycles.
- Participant characteristics and program usage data were collected.
Main Results:
- Participants identified psychosocial barriers including social issues (45%), time pressures (22%), and emotions (25%).
- Most adolescents (76%) completed problem-solving cycles, with 92% of reported diabetes problems being solved.
- Females posted more frequently to the forum; parental interaction with the website was high (87%).
Conclusions:
- Internet-based problem-solving interventions can effectively address psychosocial barriers in adolescents with type 1 diabetes.
- This program offers a viable, low-support option for clinics to enhance pediatric diabetes outcomes.
Related Concept Videos
01:15Diabetes: Management and Pharmacotherapy
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
01:22Diabetes Mellitus: Overview and Type I Subtype
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
01:12Type I Diabetes I: Introduction
Type 1 diabetes mellitus is a chronic metabolic disorder characterized by an absolute deficiency of insulin resulting from the autoimmune destruction of pancreatic β-cells. Although it can occur at any age, it is most commonly diagnosed in childhood, adolescence, or early adulthood. The loss of insulin production impairs cellular glucose uptake, resulting in persistent hyperglycemia and necessitating lifelong insulin therapy.Autoimmune Destruction of β-CellsThe hallmark of type 1 diabetes is an...
01:26Type II Diabetes I: Introduction
Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
01:16Insulin: Dosing Regimen and Adverse Effects
Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
01:27Coping Strategies: Problem Focused
Coping strategies are methods people use to manage, tolerate, or reduce the effects of stressors. These strategies involve both behavioral and psychological actions to handle stressful situations. One common approach is problem-focused coping, which aims to change or eliminate the source of stress rather than merely addressing its consequences. This method involves taking direct action to resolve the issue causing stress.
For example, consider a student who struggles to understand their...
For example, consider a student who struggles to understand their...